ST Pharm Co.,Ltd. (237690.KQ)

KRW 84900.0

(-4.61%)

Total Debt Summary of ST Pharm Co.,Ltd.

ST Pharm Co.,Ltd.'s latest annual total debt in 2023 was 192.08 Billion KRW , up 42.79% from previous year.
ST Pharm Co.,Ltd.'s latest quarterly total debt in 2024 Q1 was 184.33 Billion KRW , down -4.03% from previous quarter.
ST Pharm Co.,Ltd. reported annual total debt of 134.52 Billion KRW in 2022, up 25.12% from previous year.
ST Pharm Co.,Ltd. reported annual total debt of 107.51 Billion KRW in 2021, down -15.29% from previous year.
ST Pharm Co.,Ltd. reported quarterly total debt of 184.33 Billion KRW for 2024 Q1, down -4.03% from previous quarter.
ST Pharm Co.,Ltd. reported quarterly total debt of 142.9 Billion KRW for 2023 Q2, down -0.43% from previous quarter.

Annual Total Debt Chart of ST Pharm Co.,Ltd. (2023 - 2015)

Historical Annual Total Debt of ST Pharm Co.,Ltd. (2023 - 2015)

Year	Total Debt	Total Debt Growth
2023	192.08 Billion KRW	42.79%
2022	134.52 Billion KRW	25.12%
2021	107.51 Billion KRW	-15.29%
2020	126.92 Billion KRW	693.6%
2019	15.99 Billion KRW	13570.02%
2018	117 Million KRW	-14.29%
2017	136.5 Million KRW	-91.02%
2016	1.51 Billion KRW	-96.44%
2015	42.67 Billion KRW	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	159.54 Billion KRW	-13.45%
2024 Q1	184.33 Billion KRW	-4.03%
2023 Q2	142.9 Billion KRW	-0.43%
2023 Q4	192.08 Billion KRW	-4.7%
2023 FY	192.08 Billion KRW	42.79%
2023 Q1	143.52 Billion KRW	6.69%
2023 Q3	201.55 Billion KRW	41.04%
2022 Q3	129.13 Billion KRW	0.3%
2022 FY	134.52 Billion KRW	25.12%
2022 Q4	134.52 Billion KRW	4.17%
2022 Q2	128.75 Billion KRW	15.08%
2022 Q1	111.88 Billion KRW	4.06%
2021 Q4	107.51 Billion KRW	-15.76%
2021 Q1	126.36 Billion KRW	0.26%
2021 Q2	127.42 Billion KRW	0.83%
2021 Q3	127.62 Billion KRW	0.16%
2021 FY	107.51 Billion KRW	-15.29%
2020 Q1	15.61 Billion KRW	0.3%
2020 FY	126.92 Billion KRW	693.6%
2020 Q4	126.03 Billion KRW	702.96%
2020 Q3	15.69 Billion KRW	0.38%
2020 Q2	15.63 Billion KRW	0.12%
2019 Q2	177.34 Million KRW	-13.07%
2019 Q3	147.82 Million KRW	-16.65%
2019 Q4	15.57 Billion KRW	10433.2%
2019 Q1	204 Million KRW	74.36%
2019 FY	15.99 Billion KRW	13570.02%
2018 Q1	136.5 Million KRW	0.0%
2018 FY	117 Million KRW	-14.29%
2018 Q3	- KRW	-100.0%
2018 Q2	136.5 Million KRW	0.0%
2018 Q4	117 Million KRW	0.0%
2017 Q2	156 Million KRW	0.0%
2017 Q1	156 Million KRW	0.0%
2017 Q4	136.5 Million KRW	0.0%
2017 FY	136.5 Million KRW	-91.02%
2017 Q3	- KRW	-100.0%
2016 Q4	156 Million KRW	0.0%
2016 Q2	54.17 Billion KRW	0.0%
2016 Q1	- KRW	-100.0%
2016 Q3	156 Million KRW	-99.71%
2016 FY	1.51 Billion KRW	-96.44%
2015 FY	42.67 Billion KRW	0.0%
2015 Q4	42.67 Billion KRW	0.0%

Peer Total Debt Comparison of ST Pharm Co.,Ltd.

Name	Total Debt	Total Debt Difference
Sam Chun Dang Pharm. Co., Ltd	53.62 Billion KRW	-258.195%
Hyundai Bioscience Co., Ltd.	5.54 Billion KRW	-3363.092%
ABL Bio Inc.	43.93 Billion KRW	-337.165%
Cellid, Co., Ltd.	11.99 Billion KRW	-1501.37%